Literature DB >> 2074438

CNS and PNS effects of nimodipine.

P R Bär1, J Traber, T Schuurman, W H Gispen.   

Abstract

Calcium ions play a decisive role in a large number of processes dealing with development, regeneration after damage, and aging of elements of the nervous system. Nimodipine, a member of the 1,4-dihydropyridine chess of calcium-channel blockers, has proved to influence the calcium metabolism of neurons. This review focuses on the results of recent studies on the role of nimodipine in both the central and peripheral nervous system, during or after events that threaten the integrity or function of the nervous system.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2074438

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN： 0303-6995


  5 in total

1.  L-type calcium channels refine the neural population code of sound level.

Authors:  Calum Alex Grimsley; David Brian Green; Shobhana Sivaramakrishnan
Journal:  J Neurophysiol       Date:  2016-09-07       Impact factor: 2.714

2.  Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.

Authors:  Lois-May Young; Werner J Geldenhuys; Olwen C Domingo; Sarel F Malan; Cornelis J Van der Schyf
Journal:  Arch Pharm (Weinheim)       Date:  2016-02-19       Impact factor: 3.751

3.  Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.

Authors:  A C Kappelle; B Bravenboer; T van Buren; J Traber; D W Erkelens; W H Gispen
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.

Authors:  A C Kappelle; G Biessels; B Bravenboer; T van Buren; J Traber; D J de Wildt; W H Gispen
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

5.  Recovery of Voice After Reconstruction of the Recurrent Laryngeal Nerve and Adjuvant Nimodipine.

Authors:  P Mattsson; A Frostell; G Björck; J K E Persson; R Hakim; J Zedenius; M Svensson
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.